Arrhythmia News and Research

RSS
An arrhythmia is a problem with the speed or rhythm of the heartbeat. During an arrhythmia, the heart can beat too fast, too slow, or with an irregular rhythm. A heartbeat that is too fast is called tachycardia. A heartbeat that is too slow is called bradycardia. Most arrhythmias are harmless, but some can be serious or even life threatening. When the heart rate is too slow, too fast, or irregular, the heart may not be able to pump enough blood to the body. Lack of blood flow can damage the brain, heart, and other organs.
Major cardiovascular organizations join forces to establish independent board

Major cardiovascular organizations join forces to establish independent board

Elite athletes bounce back strong: No long-term heart risks after COVID-19 recovery

Elite athletes bounce back strong: No long-term heart risks after COVID-19 recovery

SparkMaster 2: New software automates analysis of calcium release events

SparkMaster 2: New software automates analysis of calcium release events

MRI-guided ablation improves outcomes for younger AFib patients, study shows

MRI-guided ablation improves outcomes for younger AFib patients, study shows

Bystander defibrillation improves 30-day survival even with short ambulance response times

Bystander defibrillation improves 30-day survival even with short ambulance response times

Transparent crystal ribcage for real-time imaging of lung function

Transparent crystal ribcage for real-time imaging of lung function

Miniature heart model holds the key to saving lives and enhancing patient outcomes

Miniature heart model holds the key to saving lives and enhancing patient outcomes

New method for assessing the structural changes in cardiac arrhythmia

New method for assessing the structural changes in cardiac arrhythmia

COVID-19 treatment: study evaluates ACEi and ARB effects on clinical outcomes

COVID-19 treatment: study evaluates ACEi and ARB effects on clinical outcomes

ARMGO Pharma Enrolls First Patient in Phase 2 Trial of ARM210 for the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia

ARMGO Pharma Enrolls First Patient in Phase 2 Trial of ARM210 for the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia

Catheter ablation: A new first-line treatment option for atrial fibrillation

Catheter ablation: A new first-line treatment option for atrial fibrillation

Research shows redlining's long-term impact on cardiovascular health of Black adults

Research shows redlining's long-term impact on cardiovascular health of Black adults

Black patients with ICDs have higher rate of post-implant cardiac events and risk of death

Black patients with ICDs have higher rate of post-implant cardiac events and risk of death

New heart cell atlas reveals detailed structure of the human heart

New heart cell atlas reveals detailed structure of the human heart

FKBP5 deficiency linked to atrial fibrillation

FKBP5 deficiency linked to atrial fibrillation

Researchers develop dissolving cardiac device to monitor and treat heart disease

Researchers develop dissolving cardiac device to monitor and treat heart disease

Skipping nightly toothbrushing could heighten cardiovascular disease risk

Skipping nightly toothbrushing could heighten cardiovascular disease risk

Higher-than-recommended doses of vitamin D linked to lower risk of atrial fibrillation

Higher-than-recommended doses of vitamin D linked to lower risk of atrial fibrillation

Patients affected by depression more likely to stop taking their heart medications

Patients affected by depression more likely to stop taking their heart medications

Omega-3 fatty acids linked to lower atrial fibrillation risk in U.S. veterans

Omega-3 fatty acids linked to lower atrial fibrillation risk in U.S. veterans

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.